Type 2 Diabetes
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayMaximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
300% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Acarbose
- Actoplus Met
- Actos
- Admelog
- Admelog Solostar Pen
- Afrezza
- Amaryl
- Apidra
- Apidra Solostar
- Basaglar Kwikpen
- Basaglar Tempo Pen
- Bydureon Bcise*
- Byetta 10mcg Pen
- Byetta 5mcg Pen
- Chlorpropamide*
- Cycloset
- Diabeta*
- Dm2*
- Duetact
- Farxiga
- Fiasp
- Fiasp Flextouch
- Fiasp Penfill
- Glimepiride Avpak
- Glipizide Avpak
- Glipizide Er
- Glipizide Xl
- Glucophage Xr*
- Glucophage*
- Glucotrol Xl
- Glumetza
- Glyburide
- Glyburide-metformin
- Glynase Pres-tab
- Glyxambi
- Humalog
- Humalog Junior Kwikpen
- Humalog Kwikpen
- Humalog Mix 50/50
- Humalog Mix 50/50 Kwikpen
- Humalog Mix 75/25
- Humalog Mix 75/25 Kwikpen
- Humalog Tempo Pen
- Humulin 70/30
- Humulin 70/30 Kwikpen
- Humulin N (nph)
- Humulin R
- Humulin R U-500
- Humulin R U-500 Kwikpen
- Humunlin N (nph) Kwikpen
- Insulin Aspart 70/30 Flexpen
- Insulin Aspart Flexpen
- Insulin Aspart Penfill
- Insulin Aspart Protamine
- Insulin Degludec
- Insulin Degludec Flextouch Pen
- Insulin Glargine
- Insulin Glargine Pen
- Insulin Lispro 75/25 Kwikpen*
- Insulin Lispro Junior Kwikpen*
- Insulin Lispro Kwikpen*
- Insulin Lispro*
- Invokamet
- Invokamet Xr
- Invokana
- Janumet
- Janumet Xr
- Januvia
- Jardiance
- Jentadueto
- Jentadueto Xr
- Kazano
- Kombiglyze Xr
- Lantus
- Lantus Solostar Pen;
- Levemir
- Levemir Flexpen
- Lyumjev Kwikpen U-100
- Lyumjev Kwikpen U-200
- Lyumjev Tempo Pen
- Lyumjev U-100
- Metformin
- Metformin Hcl
- Metformin Hcl Avpak
- Miglitol
- Mounjaro
- Myxredlin
- Nateglinide
- Nesina
- Novolin 70/30
- Novolin 70/30 Flexpen
- Novolin N (nph)
- Novolin N Flexpen
- Novolin R
- Novolin R Flexpen
- Novolog
- Novolog Flexpen
- Novolog Mix 70/30
- Novolog Mix 70/30 Flexpen
- Onglyza
- Orinase*
- Oseni
- Ozempic 0.25mg Doses
- Ozempic 0.5mg Doses
- Ozempic 1mg Doses
- Ozempic 2mg Doses
- Parlodel
- Pioglitazone
- Precose
- Psyllium
- Qtern
- Relion Novolin 70/30
- Relion Novolin 70/30 Flexpen
- Relion Novolin N Flexpen
- Relion Novolin R
- Relion Novolin R Flexpen
- Relion Novolog
- Relion Novolog Flexpen
- Relion Novolog Mix 70/30
- Relion Novolog Mix 70/30 Flexpen
- Repaglinide
- Rezvoglar Kwikpen
- Riomet
- Riomet Er
- Rybelsus
- Segluromet
- Semglee
- Semglee Pen
- Soliqua 100/33
- Steglatro
- Steglujan
- Symlinpen
- Synjardy
- Synjardy Xr
- Tolinase*
- Toujeo 1.5ml Prefilled Pen
- Toujeo Max 3ml Prefilled Pen
- Tradjenta
- Tresiba
- Tresiba Flextouch Pen
- Trijardy Xr
- Trulicity
- Victoza
- Welchol
- Xigduo Xr
- Xultophy 100/3.6
- Zituvio
Fund Definition
Assistance for eligible patients with copayment, coinsurance, and deductible related to prescription drugs or biologic therapy for the treatment of Type 2 Diabetes.
Grant Utilization
HealthWell estimates that patients use an average of $750 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Type 2 Diabetes
Type 2 diabetes is the most common form of diabetes and develops when the cells in the body do not respond well to, or make enough insulin, a hormone produced in the pancreas. If not treated, people with type 2 diabetes will have high blood glucose (blood sugar) levels which, over time, can lead to serious health problems including heart disease, stroke, blindness, and kidney failure. Over 37 million people in the U.S. have diabetes and type 2 diabetes accounts for approximately 90-95% of all diagnosed cases of diabetes in the U.S.
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.